<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03313063</url>
  </required_header>
  <id_info>
    <org_study_id>PPC1</org_study_id>
    <nct_id>NCT03313063</nct_id>
  </id_info>
  <brief_title>Post-Pregnancy Cardio Trial</brief_title>
  <acronym>PPC1</acronym>
  <official_title>Myocardial Characterization With Magnetic Resonance Imaging in Patients After Preeclampsia (Pilot Study)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Charite University, Berlin, Germany</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Charite University, Berlin, Germany</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Preeclampsia is a systemic pregnancy disorder and is associated with an increased
      cardiovascular risk later in life. This study will characterize myocardial tissue in patients
      after preeclampsia compared to controls and investigate potential functional and structural
      changes in the heart of preeclamptic women primarily with two methods: cardiovascular
      magnetic resonance imaging and echocardiography. A comparison between these two methods,
      where appropriate, is also envisaged.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">August 28, 2017</start_date>
  <completion_date type="Actual">June 30, 2018</completion_date>
  <primary_completion_date type="Actual">June 30, 2018</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Control</observational_model>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>any structural or functional change of the heart (combined outcome)</measure>
    <time_frame>0.5 - 20 years after delivery</time_frame>
    <description>Combined outcome: myocardial fibrosis, edema, fat infiltrates, inflammation, reduced ejection fraction, hypertrophy</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>myocardial fibrosis</measure>
    <time_frame>0.5 - 20 years after delivery</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>myocardial edema</measure>
    <time_frame>0.5 - 20 years after delivery</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>myocardial fat infiltrates</measure>
    <time_frame>0.5 - 20 years after delivery</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>myocardial inflammation</measure>
    <time_frame>0.5 - 20 years after delivery</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>myocardial hypertrophy</measure>
    <time_frame>0.5 - 20 years after delivery</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>reduced ejection fraction</measure>
    <time_frame>0.5 - 20 years after delivery</time_frame>
  </secondary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Actual">47</enrollment>
  <condition>Preeclampsia</condition>
  <arm_group>
    <arm_group_label>PE</arm_group_label>
    <description>Women with a history or preeclampsia, between 18 - 50 years of age, 0.5 - 20 years postpartum</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control</arm_group_label>
    <description>Age-matched women without any birth complications, between 18 - 50 years of age, 0.5 - 20 years postpartum</description>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        Women between 18 and 50 years of age, 0.5 - 20 years postpartum either with preeclampsia
        diagnosis during index pregnancy or without pathological findings. Controls are matched to
        cases based on age and BMI.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  postpartal window: 0.5 - 20 years

          -  cases: diagnosis of preeclampsia during the index pregnancy

          -  controls: age and BMI matched

        Exclusion Criteria:

          -  metal implants

          -  kidney insufficiency (GFR &lt; 30 ml/min/)

          -  claustrophobia

          -  contrast medium allergy

          -  current pregnancy/ lactation

          -  chronic hypertension (&gt; 140/90)

          -  diagnosis of previous cardiovascular disease

          -  body weight over 120 kg

          -  big tattoos in thorax area
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>50 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Experimental and Clinical Research Center (ECRC)</name>
      <address>
        <city>Berlin</city>
        <zip>13125</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <verification_date>July 2018</verification_date>
  <study_first_submitted>October 13, 2017</study_first_submitted>
  <study_first_submitted_qc>October 13, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">October 18, 2017</study_first_posted>
  <last_update_submitted>July 24, 2018</last_update_submitted>
  <last_update_submitted_qc>July 24, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">July 26, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Charite University, Berlin, Germany</investigator_affiliation>
    <investigator_full_name>Florian Herse</investigator_full_name>
    <investigator_title>PhD</investigator_title>
  </responsible_party>
  <keyword>magnetic resonance imaging</keyword>
  <keyword>myocard</keyword>
  <keyword>preeclampsia</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pre-Eclampsia</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

